G protein-coupled P2Y12 receptor is involved in the progression of neuropathic pain

• Published in: Biomedicine & pharmacotherapy Vol. 162; p. 114713
• Main Authors: Ming, Li-guo, Hu, Dong-xia, Zuo, Cheng, Zhang, Wen-jun
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01.06.2023
• Subjects: Antagonists; GTP-Binding Proteins; Humans; Hyperalgesia; Neuralgia - pathology; Neuropathic pain; P2Y12 receptor; Purinergic P2Y Receptor Antagonists; Receptors, G-Protein-Coupled; Signal Transduction; Spinal Cord - pathology; Treatment; P2Y12 receptor; SGCs; 3TC; NF-kB; Antagonists; IL-1β; ADP; IL-6; Neuropathic pain; MAPK, NLRP3; Treatment; TNF-α; IL-18; DRG; ATK; MEK1; ATP
• ISSN: 0753-3322; 1950-6007; 1950-6007
• DOI: 10.1016/j.biopha.2023.114713

The pathological mechanism of neuropathic pain is complex, which seriously affects the physical and mental health of patients, and its treatment is also difficult. The role of G protein-coupled P2Y12 receptor in pain has been widely recognized and affirmed. After nerve injury, stimulated cells can release large amounts of nucleotides into the extracellular matrix, act on P2Y12 receptor. Activated P2Y12 receptor activates intracellular signal transduction and is involved in the development of pain. P2Y12 receptor activation can sensitize primary sensory neurons and receive sensory information. By transmitting the integrated information through the dorsal root of the spinal cord to the secondary neurons of the posterior horn of the spinal cord. The integrated information is then transmitted to the higher center through the ascending conduction tract to produce pain. Moreover, activation of P2Y12 receptor can mediate immune cells to release pro-inflammatory factors, increase damage to nerve cells, and aggravate pain. While inhibits the activation of P2Y12 receptor can effectively relieve pain. Therefore, in this article, we described P2Y12 receptor antagonists and their pharmacological properties. In addition, we explored the potential link between P2Y12 receptor and the nervous system, discussed the intrinsic link of P2Y12 receptor and neuropathic pain and as a potential pharmacological target for pain suppression. [Display omitted] •Comprehensively synthesized the characteristics and pathological mechanisms of neuropathic pain.•Described P2Y12 receptor antagonists and their pharmacological properties.•Discussed the intrinsic link of P2Y12 receptor to neuropathic pain.•P2Y12 receptor can serve as a potential therapeutic molecular target for neuropathic pain.